We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$15.7M
Cap. Flow
-$17.7M
Cap. Flow %
-15.82%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$13.8M
2
XLRN
Acceleron Pharma
XLRN
+$3.29M
3
EPZM
Epizyme, Inc
EPZM
+$589K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
1
10x Genomics
TXG
$5.55B
$112M 99.68%
750,000
– –
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$359K 0.32%
143,759
-150,000
-51% -$589K
NVAX icon
3
Novavax
NVAX
$1.35B
– –
-66,810
Closed -$13.8M
XLRN
4
DELISTED
Acceleron Pharma
XLRN
– –
-19,100
Closed -$3.29M

Similar funds

A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
AGDR
AdamCapital Gestao de Recursos Rio De Janeiro, Brazil $18.1M AUM 32.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
WL
WiL LLC Palo Alto, California $17.5M AUM 75.04% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
SVGI
Sozo Ventures GP I Redwood City, California $16.3M AUM 66.18% 1-Year Est. Return

Foresite Capital Management I's Q4 2021 Portfolio in Review

As of Q4 2021, Foresite Capital Management I held 4 positions worth $112M, down 12% from $128M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management I withdrew a net $17.7M in Q4 2021, closing 2 positions and reducing 1 holding. Its most notable exit was Novavax, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management I's biggest Q4 2021 reduction was Epizyme, Inc, cutting an estimated $589K.
  • Foresite Capital Management I fully exited Novavax in Q4 2021, selling an estimated $13.8M.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $112M portfolio in Q4 2021.
  • Foresite Capital Management I opened 0 new positions and closed 2 in Q4 2021.
  • Foresite Capital Management I's portfolio value fell 12% quarter-over-quarter to $112M.

Based on Foresite Capital Management I's 13F filing for Q4 2021, filed 11 Feb 2022.